Kyn Therapeutics

  • BioTech/Drugs
  • Boston MA
  • 10 employees
Get Full Info

Company Overview

Website
kyntherapeutics.com
Email
Phone
(857) 273-8343
Employees
10
Industry
BioTech/Drugs
SIC Code
8731 - Commercial Physical and Biological Research
More Details

Financials & Stats

Revenue

$10B

More Financials

Recent News & Media

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium

  • Nov 26, 2024
  • pmc.ncbi.nlm.nih.gov

Cancer biotech lays off more employees in 2024, begins hunt for 'strategic options'

  • May 29, 2024
  • bizjournals.com

Having the cake and eating it? Clofazimine boosts immunotherapy while limiting side effects

  • May 13, 2024
  • sciencedirect.com

Next-generation PARP Inhibitor Demonstrates Clinical Benefit in Patients with Homologous Recombination Repair-deficient Breast Cancer | News Releases | AACR

  • Apr 8, 2024
  • aacr.org

Jilted by Bristol Myers, Ikena cuts headcount by 35% in retreat from drug discovery

  • Jan 19, 2024
  • fiercebiotech.com

Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Hodgkin Lymphoma across the United States

  • Nov 2, 2023
  • sciencedirect.com

Who is Kyn Therapeutics

Kyn Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts. Founded in December 2017, the company employs 10 people and has generated over $10,000 in revenue. Kyn Therapeutics specializes in developing cancer therapeutics focused on immuno-metabolic pathways. Their research aims to create breakthrough therapies for cancer patients who don't respond to current treatments like checkpoint inhibitors. The company leverages years of pre-clinical and clinical research to explore the potential of immuno-metabolic targets in enhancing anti-tumor immune responses. Kyn Therapeutics is committed to building a pipeline of programs that can overcome immunosuppression by modulating both the innate and adaptive immune systems. These programs have the potential to be used as monotherapies or in conjunction with existing immunotherapies. For more information, please visit kyntherapeutics.com.

Company Leadership

Alexander Constan

SVP, Non Clinical Safety and DMPK

Phone Email
Sergio Santillana

Chief Medical Officer

Phone Email

Kyn Therapeutics Industry Tags

Immunometabolism
Cancer therapeutics development
Drug development
Cancer immunotherapy
Small molecule drug design
Biologic drug design
Cancer biology
Immunology
View All Industry Tags

Companies Similar to Kyn Therapeutics

Analyze industry trends and opportunities by examining competitors and companies comparable to Kyn Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.

Company Name Revenue Number of Employees Location Founded in
10M 59 Boston, MA
10M 27 Cambridge, MA 2010
10M 23 Waltham, MA 1999
10M 2 Boston, MA
10M 46 Woburn, MA
View More Companies

FAQ

What is the location of Kyn Therapeutics's headquarters?
The headquarters of Kyn Therapeutics are situated at 645 Summer Street, Suite 101, Boston MA
What is Kyn Therapeutics's phone number?
Kyn Therapeutics's contact number is (857) 273-8343.
What is Kyn Therapeutics's official website?
The official website of Kyn Therapeutics can be found at kyntherapeutics.com.
What is Kyn Therapeutics's current revenue?
As of April 2020, Kyn Therapeutics's annual revenue reached $10B.
How many employees does Kyn Therapeutics currently have?
Kyn Therapeutics employs approximately 10+ people as of April 2020
Which industries is Kyn Therapeutics primarily operating in?
Kyn Therapeutics operates in the following industries: Biotechnology, Pharmaceutical, Therapeutics
Who is the SVP, Non Clinical Safety and DMPK of Kyn Therapeutics?
Kyn Therapeutics's SVP, Non Clinical Safety and DMPK is Alexander Constan
What are Kyn Therapeutics's industry tags?
Kyn Therapeutics's industry tags include: Immunometabolism, Cancer therapeutics development, Drug development

Employee Directory

Key Employees

Maude Tessier

Chief Business Officer

Phone Email